Neurovascular Embolization Devices Market, By Product, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Description

REPORT HIGHLIGHT

Neurovascular Embolization Devices Market size was valued at US$ 1,561.6 Million in 2024, expanding at a CAGR of 8.90% from 2025 to 2032.

Neurovascular embolization devices prevent or limit blood flow to unwanted vascular abnormalities. Neurovascular embolisation devices include aneurysm clips, liquid embolic systems, flow diversion stents, embolisation coils, and intravascular flow disruptors. A stroke occurs when the blood supply to the brain is disrupted, resulting in oxygen deprivation, brain damage, and diminished function. The most frequent cause is clots in the arteries that provide blood to the brain. Hemorrhage, which happens when blood seeps into the brain from a ruptured vessel, may even be the reason. Memory, cognitive, and linguistic issues, as well as partial paralysis, are among the long-term effects of a stroke. The increasing rates of brain stroke and aneurysms, the rise in product authorizations, the positive outcomes of research, market developments like mergers and acquisitions, the introduction of new products, and growing awareness are some of the factors that are expected to drive growth in the global market for neurovascular embolization devices over the forecast period. The growing number of cases and research funding are also expected to help the worldwide market's expansion over the course of the projected period.

Neurovascular Embolization Devices Market- Market Dynamics

Increased Brain Stroke and Aneurysm Cases

Throughout the forecast period, the rising number of brain stroke and aneurysm cases is anticipated to propel the expansion of the global neurovascular embolization devices market. The World Stroke Organization, for example, claims that epidemic proportions of stroke have already been reached. Over 12.2 million individuals are likely to have their first stroke this year, and 6.5 million are expected to die as a result, meaning that 1 in 4 adults over 25 will have a stroke at some point in their lives. Worldwide, more than 110 million people have had a stroke at some time in their life. Over 60% of strokes occur in those under 70, and over 16% occur in people under 50, despite the fact that the prevalence of stroke rises sharply with age. Additionally, NHS England estimates that 1 in 12,500 people in England suffer from a burst brain aneurysm annually. In addition, the Brain Aneurysm Foundation estimates that over 6.0 million Americans suffer from brain aneurysms each year, and over 3.0% of persons in the United Kingdom suffer from one. Moreover, the NIH reports that the prevalence of cerebral aneurysms is approximately 3.2% worldwide, with a standard age of 50 and a gender ratio of 1:1 overall. After age 50, this ratio varies significantly, with a growing female predominance that closes at 2:1. This is thought to be because lower levels of circulating estrogen cause the collagen range of the vascular tissue to diminish.

Neurovascular Embolization Devices Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.90% over the forecast period (2025-2032)

Based on product segmentation, the embolic coils were predicted to show maximum market share in the year 2024

Based on end use segmentation, hospitals were the leading category in 2024

On the basis of region, North America was the leading revenue generator in 2024

Neurovascular Embolization Devices Market- Segmentation Analysis:

The Global Neurovascular Embolization Devices Market is segmented on the basis of Product, End Use, and Region.

On the basis of product, the market is segregated into Liquid Embolic Agents, Embolic Coils, Aneurysm Clips, Flow Diversion Devices, and Others. In 2024, the market was dominated by the embolic coils category. Complex platinum devices called embolic coils are inserted into blood arteries to cause clots to form. These coils successfully block aneurysms and other vascular anomalies, lowering the possibility of rupture and ensuing bleeding. Because of their adaptability to a variety of anatomical complications, they are very popular. The development of bioactive and detachable coils has improved the field's efficacy and safety as a result of continuous research and development efforts. Furthermore, one of the most important developments in neurovascular treatments is the use of liquid emboli.

Based on end use, the market is divided into Hospitals, Specialty Clinics, and Others. In 2024, the hospitals category held a dominant market share. Hospitals are the main locations for cutting-edge medical treatments like neurovascular embolization because of their sophisticated technology, large infrastructure, and highly qualified medical personnel. With the newest imaging equipment and interventional suites, these facilities frequently have dedicated neuro interventional units that enable accurate diagnosis and customized care. In hospital settings, having qualified neurosurgeons, interventional radiologists, and neurologists guarantees patients with disorders like aneurysms and arteriovenous malformations full, multidisciplinary care.

Neurovascular Embolization Devices Market- Geographical Insights

In 2024, North America held a dominant position in the global market for Neurovascular Embolization Devices. The market for neurovascular embolization devices is substantial in North America, particularly in the United States and Canada. These countries have high rates of neurovascular diseases, sophisticated healthcare systems, and growing medical expenses. The growth of the regional marketplace is significantly impacted by the heightened government initiatives and manufacturer research and development (R&D) spending. Additionally, the introduction of new products by major industry players to diversify their product lines contributes to the growth of the sector. For instance, India Medtronic's fourth-generation flow deflector, the Pipeline Vantage with Shield Technology, which has a CE mark, was created in June 2022 for endovascular treatment of cerebral aneurysms.

However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR. The increasing prevalence of neurological problems, technical breakthroughs, and the growing burden of target diseases are some of the causes of this. Key players' presence and growing healthcare costs are two further factors fueling the region's expansion. The market is also expected to grow more rapidly in the forecast period due to the regional expansion of major players and significant unexplored prospects in Asia Pacific. Three of the biggest suppliers to the neurovascular embolization device market in the area are China, India, and Japan.

Neurovascular Embolization Devices Market- Competitive Landscape:

Key companies in the neurovascular embolization devices are Medtronic plc, Stryker Corporation, Johnson & Johnson Inc., B. Braun Melsungen AG., Integra LifeSciences Corporation, and others. The primary producers of neurovascular embolization devices are concentrating on mergers and acquisitions in order to diversify their product lines. In hospitals and other institutions, businesses are holding conferences and training sessions to inform surgeons and practitioners about the new neurovascular embolization devices. Furthermore, growth initiatives, including new product releases, regulatory approvals, expansions, partnerships, acquisitions, and collaborations, are the main emphasis of the major businesses. For instance, MicroVention, Inc., a neurovascular company under Terumo Corporation, stated in July 2023 that its intravascular device, WEB, has released 5-year monitoring data. In order to make the Aneurysm Embolization Technology more adaptable to aneurysms of different sizes and types, they also included two new sizes (SL 7x2 and SL 6x2). The product is on display at Booth 615 at SNIS 2023 in San Diego. Throughout the projection period, the demand for neurovascular embolization devices will rise as a result of these developments.

Recent Development

February 2023: The first patient treated in Germany as part of the EMBO-Post Market Surveillance Registry, the company's upcoming multicenter registry investigation of its IMPEDE and IMPEDE-FX Embolization Plugs when used for peripheral vascular embolization, was reported by Shape Memory Medical Inc., a manufacturer of shape memory polymers for the peripheral and neurovascular markets.

July 2022: While attending the 19th Annual Conference of the Society of Neurointerventional Surgery (SNIS) in Toronto, Rapid Medical, a company that designs innovative neurovascular devices, received FDA 510(k) permission for TIGERTRIEVER 13 for major artery occlusions.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Medtronic plc
Stryker Corporation
Johnson & Johnson Inc.
B. Braun Melsungen AG.
Integra LifeSciences Corporation
Lepu Medical Technology (Beijing) Co.
Terumo Corporation
Acandis GmBH
Phenox GmBH
Shape Memory Medical Inc.
Others

GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

Liquid Embolic Agents
Embolic Coils
Aneurysm Clips
Flow Diversion Devices
Others

GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

Hospitals
Specialty Clinics
Others

GLOBAL NEUROVASCULAR EMBOLIZATION DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV4485

1. Neurovascular Embolization Devices Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Neurovascular Embolization Devices Market Snippet by Product
- 2.1.2. Neurovascular Embolization Devices Market Snippet by End Use
- 2.1.3. Neurovascular Embolization Devices Market Snippet by Country
- 2.1.4. Neurovascular Embolization Devices Market Snippet by Region
2.2. Competitive Insights

3. Neurovascular Embolization Devices Key Market Trends

3.1. Neurovascular Embolization Devices Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Neurovascular Embolization Devices Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Neurovascular Embolization Devices Market Opportunities
3.4. Neurovascular Embolization Devices Market Future Trends

4. Neurovascular Embolization Devices Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Neurovascular Embolization Devices Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Neurovascular Embolization Devices Market Landscape

6.1. Neurovascular Embolization Devices Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Neurovascular Embolization Devices Market - By Product

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
- 7.1.2. Liquid Embolic Agents
- 7.1.3. Embolic Coils
- 7.1.4. Aneurysm Clips
- 7.1.5. Flow Diversion Devices
- 7.1.6. Others

8. Neurovascular Embolization Devices Market - By End Use

8.1. Overview
- 8.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
- 8.1.2. Hospitals
- 8.1.3. Specialty Clinics
- 8.1.4. Others

9. Neurovascular Embolization Devices Market- By Geography

9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
9.2. North America
- 9.2.1. Overview
- 9.2.2. Neurovascular Embolization Devices Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.2.6. U.S.
  - 9.2.6.1. Overview
  - 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.6.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.2.6.4. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.2.7. Canada
  - 9.2.7.1. Overview
  - 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.2.7.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.2.7.4. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.3. Europe
- 9.3.1. Overview
- 9.3.2. Neurovascular Embolization Devices Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.6. Germany
  - 9.3.6.1. Overview
  - 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.6.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.6.4. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.7. France
  - 9.3.7.1. Overview
  - 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.7.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.7.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.8. Italy
  - 9.3.8.1. Overview
  - 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.8.4. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.9. Spain
  - 9.3.9.1. Overview
  - 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.9.4. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.10. United Kingdom
  - 9.3.10.1. Overview
  - 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.10.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.10.4. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.11. Russia
  - 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.11.3. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.12. Netherlands
  - 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.12.3. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.13. Sweden
  - 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.13.3. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.14. Poland
  - 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.14.3. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.3.15. Rest of Europe
  - 9.3.15.1. Overview
  - 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.3.15.4. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Neurovascular Embolization Devices Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.6. India
  - 9.4.6.1. Overview
  - 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.6.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.6.4. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.7. China
  - 9.4.7.1. Overview
  - 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.7.4. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.8. South Korea
  - 9.4.8.1. Overview
  - 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.8.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.8.4. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.9. Japan
  - 9.4.9.1. Overview
  - 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.9.4. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.10. Australia
  - 9.4.10.1. Overview
  - 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.10.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.10.4. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.11. Thailand
  - 9.4.11.1. Overview
  - 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.11.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.11.4. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.12. Indonesia
  - 9.4.12.1. Overview
  - 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.12.4. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.13. Philippines
  - 9.4.13.1. Overview
  - 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.13.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.13.4. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.4.14. Rest of APAC
  - 9.4.14.1. Overview
  - 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.4.14.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.4.14.4. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Neurovascular Embolization Devices Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.6. Brazil
  - 9.5.6.1. Overview
  - 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.6.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.5.6.4. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.7. Mexico
  - 9.5.7.1. Overview
  - 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.7.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.5.7.4. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.8. Argentina
  - 9.5.8.1. Overview
  - 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.8.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.5.8.4. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.9. Colombia
  - 9.5.9.1. Overview
  - 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.9.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.5.9.4. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.5.10. Rest of LATAM
  - 9.5.10.1. Overview
  - 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.5.10.4. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Neurovascular Embolization Devices Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.6. Saudi Arabia
  - 9.6.6.1. Overview
  - 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.6.4. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.7. United Arab Emirates
  - 9.6.7.1. Overview
  - 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.7.4. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.8. Israel
  - 9.6.8.1. Overview
  - 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.8.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.8.4. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.9. Turkey
  - 9.6.9.1. Overview
  - 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.9.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.9.4. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.10. Algeria
  - 9.6.10.1. Overview
  - 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.10.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.10.4. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.11. Egypt
  - 9.6.11.1. Overview
  - 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.11.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.11.4. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
- 9.6.12. Rest of MEA
  - 9.6.12.1. Overview
  - 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 9.6.12.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
  - 9.6.12.4. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Neurovascular Embolization Devices Industry

10.1. Competitive Dashboard
10.2. Company Profiles
- 10.2.1. Medtronic plc
- 10.2.2. Stryker Corporation
- 10.2.3. Johnson & Johnson Inc.
- 10.2.4. B. Braun Melsungen AG.
- 10.2.5. Integra LifeSciences Corporation
- 10.2.6. Lepu Medical Technology (Beijing) Co.
- 10.2.7. Terumo Corporation
- 10.2.8. Acandis GmBH
- 10.2.9. Phenox GmBH
- 10.2.10. Shape Memory Medical Inc.
- 10.2.11. Others

11. 360 Degree Analyst View

12. Appendix

12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us